Literature DB >> 16685130

The use of low-dose insulin in cardiogenic shock due to combined overdose of verapamil, enalapril and metoprolol.

Tal Hasin1, David Leibowitz, Meir Antopolsky, Tova Chajek-Shaul.   

Abstract

We describe a case of severe heart failure due to the combined effect of verapamil and enalapril overdose in a patient treated regularly with metoprolol. The patient was dependent for 2 days on glucagon and dopamine infusion but remained oliguric, with deteriorating renal function. Marked improvement in all hemodynamic parameters was noted a short time after initiation of treatment with low-dose insulin infusion (1-2 units/h), which allowed the prompt withdrawal of glucagon and dopamine. We discuss the efficacy of glucose-insulin treatment in toxic cardiac depression and suggest that a low dose may be beneficial in similar cases. 2006 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16685130     DOI: 10.1159/000093191

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  3 in total

1.  Successful treatment of refractory hypotension, noncardiogenic pulmonary edema and acute kidney injury after an overdose of amlodipine.

Authors:  Vivek B Kute; Pankaj R Shah; Kamal R Goplani; Manoj R Gumber; A V Vanikar; Hargovind L Trivedi
Journal:  Indian J Crit Care Med       Date:  2011-07

2.  Management of calcium channel antagonist overdose with hyperinsulinemia-euglycemia therapy: case series and review of the literature.

Authors:  Shiwan K Shah; Sanjeev Kumar Goswami; Rajesh V Babu; Gulshan Sharma; Alexander G Duarte
Journal:  Case Rep Crit Care       Date:  2012-02-14

Review 3.  Treatment for calcium channel blocker poisoning: a systematic review.

Authors:  M St-Onge; P-A Dubé; S Gosselin; C Guimont; J Godwin; P M Archambault; J-M Chauny; A J Frenette; M Darveau; N Le Sage; J Poitras; J Provencher; D N Juurlink; R Blais
Journal:  Clin Toxicol (Phila)       Date:  2014-10-06       Impact factor: 4.467

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.